Sarepta Therapeutics is a biopharmaceutical company in Massachusetts that develops RNA-based and gene therapies. It lobbies Congress on Medicare and Medicaid rules (including the Medicaid drug rebate program and state waivers), federal budget and appropriations, and coverage and payment issues for gene and value‑based therapies, including treatments for Duchenne muscular dystrophy.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JENNIFER B YOUNG
The latest disclosures for this client.
TARPLIN, DOWNS & YOUNG, LLC
Q2TARPLIN, DOWNS & YOUNG, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
TARPLIN, DOWNS & YOUNG, LLC
mr PARICK BRAERTON CARROLL
TARPLIN, DOWNS & YOUNG, LLC
PAMELA SMITH
TARPLIN, DOWNS & YOUNG, LLC
RAISSA H DOWNS
TARPLIN, DOWNS & YOUNG, LLC
CHARLOTTE SPEARS IVANCIC
TARPLIN, DOWNS & YOUNG, LLC
ELIZABETH T MURRAY
TARPLIN, DOWNS & YOUNG, LLC
EMILY H MURRY
TARPLIN, DOWNS & YOUNG, LLC
MEG JOSEPH
TARPLIN, DOWNS & YOUNG, LLC
TARPLIN, DOWNS & YOUNG, LLC
4ATARPLIN, DOWNS & YOUNG, LLC
4ATARPLIN, DOWNS & YOUNG, LLC
Q4TARPLIN, DOWNS & YOUNG, LLC
Q3TARPLIN, DOWNS & YOUNG, LLC
Q2TARPLIN, DOWNS & YOUNG, LLC
Q1